Erol R. Akdamar Sells 2,900 Shares of HCA Healthcare, Inc. (NYSE:HCA) Stock

HCA Healthcare, Inc. (NYSE:HCA) insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

HCA Healthcare Trading Down 0.7 %

Shares of NYSE HCA opened at $342.96 on Friday. The business has a 50-day moving average price of $386.00 and a two-hundred day moving average price of $357.03. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The firm has a market capitalization of $86.87 billion, a PE ratio of 15.40, a PEG ratio of 1.34 and a beta of 1.68. HCA Healthcare, Inc. has a one year low of $238.82 and a one year high of $417.14.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.77%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of HCA. Terra Nova Asset Management LLC grew its stake in shares of HCA Healthcare by 0.3% in the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock valued at $3,297,000 after buying an additional 26 shares in the last quarter. Massmutual Trust Co. FSB ADV raised its holdings in HCA Healthcare by 7.4% during the third quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock valued at $171,000 after buying an additional 29 shares in the last quarter. Waldron Private Wealth LLC increased its holdings in shares of HCA Healthcare by 1.8% during the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock valued at $683,000 after acquiring an additional 29 shares during the last quarter. Brookstone Capital Management boosted its position in HCA Healthcare by 0.7% during the third quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock worth $1,652,000 after purchasing an additional 30 shares during the period. Finally, UMB Bank n.a. raised its position in shares of HCA Healthcare by 2.4% in the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock valued at $529,000 after purchasing an additional 30 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently commented on the company. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. TD Cowen decreased their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Oppenheimer increased their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a report on Monday, October 28th. Truist Financial increased their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Finally, Royal Bank of Canada lifted their target price on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a report on Friday, August 23rd. Five analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $385.00.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.